| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 96.38B | 94.80B | 86.52B | 84.13B | 80.71B | 76.40B |
| Gross Profit | 12.67B | 11.81B | 9.68B | 8.21B | 11.15B | 10.55B |
| EBITDA | 10.99B | 10.60B | 8.75B | 7.81B | 10.60B | 9.91B |
| Net Income | 3.57B | 3.61B | 4.59B | 4.13B | 5.25B | 5.59B |
Balance Sheet | ||||||
| Total Assets | 137.66B | 140.77B | 134.27B | 124.15B | 126.82B | 129.70B |
| Cash, Cash Equivalents and Short-Term Investments | 8.90B | 11.38B | 13.43B | 10.30B | 12.06B | 13.53B |
| Total Debt | 28.75B | 29.60B | 27.21B | 24.64B | 24.79B | 24.82B |
| Total Liabilities | 51.90B | 54.93B | 50.34B | 45.57B | 48.25B | 49.41B |
| Stockholders Equity | 79.26B | 78.68B | 77.01B | 72.23B | 72.29B | 73.61B |
Cash Flow | ||||||
| Free Cash Flow | 594.00M | -1.13B | 5.09B | -2.15B | 2.24B | 3.33B |
| Operating Cash Flow | 2.49B | 8.77B | 11.40B | 2.58B | 9.58B | 11.64B |
| Investing Cash Flow | -2.66B | -9.37B | -6.10B | -1.15B | -4.70B | 893.00M |
| Financing Cash Flow | -1.53B | -1.50B | -2.58B | -3.18B | -6.42B | -9.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ¥153.43B | 9.24 | 3.97% | 2.71% | -0.03% | 120.35% | |
64 Neutral | ¥60.90B | 8.00 | ― | 2.67% | 6.26% | -11.38% | |
62 Neutral | ¥140.60B | 4.80 | 3.57% | 1.31% | 1.64% | -10.74% | |
62 Neutral | ¥864.46B | 9.64 | 2.55% | 3.51% | 3.91% | -22.16% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ¥36.10B | -9.37 | -0.13% | 2.31% | -10.04% | 43.13% | |
59 Neutral | ¥173.51B | 8.74 | 1.66% | 1.53% | -2.89% | -15.89% |